"T-Lymphocyte Subsets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.
Descriptor ID |
D016176
|
MeSH Number(s) |
A11.118.637.555.567.550.500 A11.118.637.555.567.569.500 A15.145.229.637.555.567.550.500 A15.145.229.637.555.567.569.500 A15.382.490.555.567.550.500 A15.382.490.555.567.569.500
|
Concept/Terms |
T-Lymphocyte Subsets- T-Lymphocyte Subsets
- Subset, T-Lymphocyte
- Subsets, T-Lymphocyte
- T Lymphocyte Subsets
- T-Lymphocyte Subset
- T-Cell Subsets
- Subset, T-Cell
- Subsets, T-Cell
- T Cell Subsets
- T-Cell Subset
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocyte Subsets".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocyte Subsets".
This graph shows the total number of publications written about "T-Lymphocyte Subsets" by people in this website by year, and whether "T-Lymphocyte Subsets" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 1 | 3 |
1997 | 2 | 0 | 2 |
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2001 | 3 | 2 | 5 |
2002 | 2 | 1 | 3 |
2003 | 3 | 3 | 6 |
2004 | 2 | 0 | 2 |
2005 | 3 | 2 | 5 |
2006 | 0 | 4 | 4 |
2007 | 1 | 3 | 4 |
2008 | 1 | 1 | 2 |
2009 | 7 | 2 | 9 |
2010 | 3 | 2 | 5 |
2011 | 4 | 2 | 6 |
2012 | 3 | 1 | 4 |
2013 | 1 | 4 | 5 |
2014 | 4 | 4 | 8 |
2015 | 2 | 3 | 5 |
2016 | 1 | 4 | 5 |
2017 | 3 | 3 | 6 |
2018 | 2 | 2 | 4 |
2019 | 2 | 2 | 4 |
2020 | 0 | 4 | 4 |
2021 | 2 | 4 | 6 |
2022 | 1 | 2 | 3 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocyte Subsets" by people in Profiles.
-
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nat Cancer. 2024 Jul; 5(7):1010-1023.
-
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitis. Immunology. 2024 Feb; 171(2):277-285.
-
TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4+ T-cell subsets in Leishmania donovani infection. Exp Parasitol. 2023 Dec; 255:108645.
-
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. 2023 01; 4(1):62-80.
-
Longitudinal Analysis of the Phenotype, Transcriptional Profile, and Anatomic Location of Memory CD8 T Cell Subsets after Acute Viral Infection. J Virol. 2023 01 31; 97(1):e0155622.
-
Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide. Blood Adv. 2022 09 13; 6(17):4994-5008.
-
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression. Blood Cancer Discov. 2022 09 06; 3(5):428-443.
-
Distinct phenotypic states and spatial distribution of CD8+ T?cell clonotypes in human brain metastases. Cell Rep Med. 2022 05 17; 3(5):100620.
-
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022 02 14; 40(2):153-167.e11.
-
Coenzyme A fuels T?cell anti-tumor immunity. Cell Metab. 2021 12 07; 33(12):2415-2427.e6.